Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Thomas Kartika

Concepts (73)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thrombosis
5
2026
398
1.210
Why?
Platelet Aggregation
2
2026
99
0.970
Why?
Platelet Membrane Glycoproteins
1
2026
31
0.960
Why?
Receptors, IgG
1
2026
77
0.940
Why?
Receptors, Cell Surface
1
2026
371
0.810
Why?
Blood Platelets
2
2026
382
0.790
Why?
Hirudins
1
2023
52
0.780
Why?
Fibrinolytic Agents
1
2026
303
0.780
Why?
Protein Kinase Inhibitors
3
2026
983
0.740
Why?
Extracorporeal Membrane Oxygenation
2
2023
370
0.730
Why?
Venous Thrombosis
2
2022
199
0.300
Why?
Neoplasms
5
2023
2954
0.300
Why?
Venous Thromboembolism
2
2023
332
0.270
Why?
Genetic Diseases, X-Linked
1
2026
26
0.240
Why?
Agammaglobulinemia
1
2026
36
0.240
Why?
Clot Retraction
1
2025
2
0.220
Why?
Drug Repositioning
1
2025
41
0.220
Why?
Small Molecule Libraries
1
2025
113
0.200
Why?
Hematology
1
2023
21
0.190
Why?
Hematologic Diseases
1
2023
66
0.190
Why?
High-Throughput Screening Assays
1
2025
179
0.190
Why?
von Willebrand Diseases
1
2023
28
0.190
Why?
General Practice
1
2022
32
0.180
Why?
Heparin
1
2023
247
0.180
Why?
Hemostatics
1
2023
66
0.180
Why?
Cyclin-Dependent Kinase 4
1
2022
52
0.170
Why?
Cyclin-Dependent Kinase 6
1
2022
49
0.170
Why?
Hemorrhage
2
2023
825
0.170
Why?
Platelet Aggregation Inhibitors
1
2025
499
0.160
Why?
Lymphoma
1
2022
251
0.160
Why?
Transplantation, Autologous
1
2022
306
0.160
Why?
Bone Marrow Transplantation
1
2022
301
0.160
Why?
Recombinant Proteins
1
2023
1361
0.160
Why?
Respiratory Insufficiency
1
2023
330
0.150
Why?
Peptide Fragments
1
2023
693
0.150
Why?
Breast Neoplasms
2
2023
2418
0.150
Why?
Anticoagulants
1
2023
746
0.130
Why?
Tissue and Organ Procurement
1
2022
305
0.130
Why?
Hematopoietic Stem Cell Transplantation
1
2022
704
0.110
Why?
Humans
14
2026
146342
0.100
Why?
Retrospective Studies
4
2023
17438
0.090
Why?
Signal Transduction
1
2026
5246
0.090
Why?
Antineoplastic Agents
1
2020
2219
0.070
Why?
Immunotherapy
2
2022
671
0.060
Why?
Hematologic Tests
1
2023
22
0.050
Why?
Adult
2
2023
41087
0.050
Why?
Deamino Arginine Vasopressin
1
2023
15
0.050
Why?
Catheterization
1
2023
179
0.050
Why?
von Willebrand Factor
1
2023
84
0.050
Why?
Hormone Replacement Therapy
1
2023
107
0.040
Why?
Hemostasis
1
2023
100
0.040
Why?
Clinical Trials, Phase I as Topic
1
2020
49
0.040
Why?
Transplantation, Homologous
1
2022
416
0.040
Why?
Estrogens
1
2023
364
0.040
Why?
B7-H1 Antigen
1
2022
245
0.040
Why?
Consensus
1
2022
467
0.040
Why?
Probability
1
2020
309
0.040
Why?
Flow Cytometry
1
2022
1163
0.030
Why?
Risk Factors
2
2023
10921
0.030
Why?
Medical Oncology
1
2020
345
0.030
Why?
Precision Medicine
1
2020
462
0.030
Why?
Anxiety
1
2023
1125
0.030
Why?
Disease Progression
1
2023
2867
0.030
Why?
Biomarkers, Tumor
1
2022
1339
0.030
Why?
Registries
1
2023
2400
0.030
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2023
1998
0.020
Why?
Cohort Studies
1
2023
6077
0.020
Why?
Risk Assessment
1
2022
3712
0.020
Why?
Aged, 80 and over
1
2023
8391
0.020
Why?
Middle Aged
2
2023
36619
0.020
Why?
Mutation
1
2022
4093
0.020
Why?
Female
2
2023
79499
0.010
Why?
Aged
1
2023
26432
0.010
Why?
Kartika's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)